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Abstract
Objective
To determine whether a tailored multifaceted implementation strategy improves the initial
management of patients with suspected encephalitis.
Design
Pragmatic two arm cluster randomised controlled trial.
Setting
Hospitals within the United Kingdom.
Participants
Twenty-four hospitals nested within 12 postgraduate deaneries. Patients were identified ret-
rospectively by searching discharge, microbiology, radiology and pharmacy records and
included if they met clinical criteria or had a recorded suspicion of encephalitis.
Intervention
An implementation strategy designed to overcome barriers to change, comprising local
action planning, education and training, feedback on performance, a lumbar puncture pack
and a range of optional components.
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Outcomes
The primary outcome was the proportion of patients with suspected encephalitis undergoing
diagnostic lumbar puncture within 12 hours of admission and starting aciclovir treatment
within six hours. Secondary outcomes included the proportions of adults and children who
had a lumbar puncture, who had appropriate cerebrospinal fluid investigations, and who had
appropriate radiological imaging within 24 hours of admission. Data were collected from
patient records for 12 months before and 12 months during the intervention period, and ana-
lysed blind to allocation.
Results
13 hospitals were randomised to intervention and 11 to control (no intervention), with 266
and 223 patients with suspected encephalitis identified respectively. There was no signifi-
cant difference in primary outcome between intervention and control hospitals (13.5% and
14.8% respectively, p = 0.619; treatment effect -0.188, 95% confidence interval -0.927 to
0.552), but both had improved compared to pre-intervention (8.5%).
Conclusion
The improvement in both intervention and control arms may reflect overall progress in man-
agement of encephalitis through wider awareness and education.
Trial registration
Controlled Trials: ISRCTN06886935.
Background
There is accumulating evidence that the clinical management of patients with suspected cen-
tral nervous system (CNS) infections does not meet recommended standards, resulting in lost
years and reduced quality of life [1–5]. In the United Kingdom (UK), encephalitis affects
between five to nine people per 100,000 every year [6] and is most commonly caused by herpes
simplex virus (HSV) type 1 [7–9]. Other causes, including antibody-associated encephalitis,
are being recognised increasingly [10]. HSV encephalitis is treated with aciclovir and prompt
treatment significantly improves patient outcomes [11–13]. Long-term outcomes from
encephalitis are still not understood fully but sequelae include disabilities such as concentra-
tion difficulties, behavioural and speech disorders, memory loss and epilepsy [14–16], all of
which impact on return to work [15].
HSV encephalitis is relatively rare but patients presenting with clinical features consistent
with suspected encephalitis frequently seek medical advice [8]. Encephalitis typically presents
with one or more of headache, fever, new-onset seizures, altered consciousness, and beha-
vioural disturbances [17,18]. However, its variable and non-specific features often result in
delayed diagnosis and treatment, especially in children who may only present with fever and
irritability [5,19]. In addition, delays in performing one of the main diagnostic techniques, a
lumbar puncture, may further hamper treatment [20–24]. Previous studies have noted delays
between two and 408 hours [2, 11], possibly due to a lack of training, difficulty in finding
appropriate equipment, and delays for a computerised tomography (CT) scan [24]. Treatment
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with aciclovir is also often delayed, with admission to treatment times ranging from 30 min-
utes to 432 hours after admission [1,2,11] although the reasons behind this are less clear.
Clinical guidelines have been developed in response to these concerns [8,25]. However, dis-
semination of guidelines alone does not usually bring about significant changes in clinical
practice [26–28]. There is a growing evidence base on interventions to promote guideline
implementation, but it remains difficult to predict with any confidence which intervention
will work best for a given context and targeted behaviour [29]. Ideally, interventions to
improve clinical behaviour should be tailored according to identified barriers and needs, pref-
erably focusing on those most amenable to change [30]. Such strategies are often multifaceted,
combining different interventions with the intention of targeting a range of barriers, although
they are not necessarily more effective than single interventions [31].
The UK Medical Research Council advocates a systematic approach to the development
and evaluation of such complex interventions [32,33]. We developed a tailored multifaceted
implementation strategy to promote adherence to national guidelines on the initial manage-
ment of suspected encephalitis [30,34] and evaluated its effectiveness within a cluster rando-
mised trial.
Methods
Study design
We conducted a cluster randomised controlled trial with National Health Service (NHS) post-
graduate deaneries as the unit of randomisation [35]. Deaneries are responsible for postgradu-
ate medical training.
Participants
Hospitals. This trial took place in the context of a wider research programme Understand-
ing and Improving the Outcome of Encephalitis (ENCEPH UK) which comprised several stud-
ies. To reduce the likelihood of any unintended co-intervention effects we sought hospitals not
directly participating in other ENCEPH UK studies. Sites had to have facilities to perform lum-
bar punctures and neuroimaging and be willing to be randomised to intervention or control
arms. We recruited a range of hospitals providing secondary and tertiary (specialist) adult and
paediatric care, to broadly represent national provision and ensure generalisable findings.
We were aware that trainee doctors, one key target intervention group, work and rotate
between different hospitals within postgraduate deaneries. We therefore used deaneries as the
unit of randomisation as randomising hospitals to intervention and control arms within the
same deanery might have risked contamination.
We assessed all 266 acute hospital trusts in England, Wales and Scotland for eligibility.
After excluding 47 participating in other ENCEPH UK studies and 10 specialist hospitals not
usually providing routine care for suspected encephalitis patients (e.g. orthopaedics) we
invited 209 hospitals to participate via senior members of medical staff.
Patients. We identified patients with features suggestive of suspected encephalitis using
criteria adapted from previous studies [1,9].
• Acute or sub-acute (less than four weeks) alteration in consciousness, cognition, personality
or behaviour persisting for more than twenty-four hours. Personality or behaviour change
included agitation, psychosis, somnolence, insomnia, catatonia, mood liability, altered sleep
pattern and (in children) new-onset enuresis or irritability. Plus any two of:
• fever (�38˚C) or prodromal illness—acute or sub-acute
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• new-onset seizures; focal neurological signs of acute or sub-acute onset, including focal
weakness, oromotor dysfunction, movement disorders (chorea, athetosis, dystonia, hemi-
ballismus, stereotypies, orolingual dyskinesia and tics) Parkinsonism (bradykinesia,
tremor, rigidity and postural instability) and amnesia
• pleocytosis (cerebrospinal fluid [CSF] white cell count of more than four cells per
microliter)
• neuroimaging compatible with encephalitis
• electroencephalogram (EEG) compatible with encephalitis
• Clinical suspicion of encephalitis noted during the index presentation.
• Clinical suspicion of encephalitis, and the patient died before investigations were completed.
Intervention
The intervention development and content has been published previously [30]. In brief, using
theoretically informed semi-structured interviews based upon the Theoretical Domains
Framework [36,37], we explored barriers and enablers to the recommended initial manage-
ment of suspected encephalitis, specifically performing lumbar punctures and initiating antivi-
ral therapy within 6 hours. This framework has previously been used to understand clinical
behaviour across a wide range of healthcare settings [37–45]. We matched behaviour change
techniques [34] targeting clinicians to the most salient barriers and enablers and embedded
them within an implementation package [30]. The implementation package comprised core
interventions, delivered to all hospitals, and optional interventions, which hospitals could use
depending on locally available resources and skills. Core interventions included educational
and action planning meetings, feedback of pre-intervention audit data and provision of lum-
bar puncture kits within refillable boxes. Optional interventions included decision support via
phone apps and algorithms, an online quiz, prompts and posters, personalised invitation let-
ters to attend educational meetings and a quality improvement cycle pack (materials available
via http://www.braininfectionsuk.org/RCTWebsite/). We presented the package at a one-day
meeting of senior doctors and nurses from intervention hospitals. These clinical leads gener-
ally represented a range of specialties, mainly paediatrics, general medicine, neurology, infec-
tious disease and microbiology, with varying levels of interest and expertise in brain infections.
We emphasised their roles in directly delivering the various intervention components locally
and recommended that they each convene an action planning meeting on return to their hos-
pitals. All intervention sites received on-going support and materials by a researcher (RB) in
addition to the core interventions. This was a pragmatic trial and all intervention sites could
choose to what extent they engaged with intervention components although the core elements
represented minimum requirements for participation [46]. Control sites received no interven-
tion except for training and support to collect study data.
Outcomes
The primary outcome was a composite of the proportion of patients with suspected encephali-
tis whose care met both of the following criteria: a lumbar puncture performed within 12
hours of hospital admission unless clinically contraindicated; and intravenous aciclovir given
within six hours of admission to hospital.
Secondary outcomes included the proportions of patients with suspected encephalitis
who:
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• Were started on intravenous aciclovir within an appropriate dosage range for a neurological
presentation (adults and children analysed separately).
• Had a lumbar puncture performed within 12 hours of admission unless there was a clinical
contraindication.
• Had a lumbar puncture at any point during the index presentation.
• Had either magnetic resonance imaging (MRI) or CT scan within 24 hours of admission.
• Had a lumbar puncture, who had the following CSF investigations performed: calculation of
the plasma to CSF glucose ratio and having HSV polymerase chain reaction (PCR)
performed.
Data collection
We used retrospectively extracted pre-intervention data from case notes between 3rd February
2013 and 2nd February 2014 to provide data for the feedback intervention. We collected trial
outcome data between 3rd February 2014 and 2nd February 2015 within the year following the
launch of the implementation package.
Patients were identified during these two time periods using four methods; discharge code
search for encephalitis, a microbiology search for patients who had had a lumbar puncture,
patients who had received intravenous (IV) aciclovir for anything other than a dermatological
condition and patients who had had either a CT head or MRI head. We used these combined
approaches to maximise likelihood of case identification. The first two methods were compul-
sory at each site to reduce the likelihood of differences in case mix potentially resulting from
different methods of detection confounding trial outcomes. We included both adult and paedi-
atric cases, excluding neonates (up to four weeks) where management is different. We aimed
to identify at least 20 cases per site with a maximum limit of 40 cases per site to preserve bal-
ance between sites. Given the large numbers of patients with records of CSF examination from
all lumbar punctures, we asked local staff to order all cases by surname and date of birth before
selecting every tenth case if there were less than 100 patients (i.e. a systematic 10% sample),
and every twentieth case if there was over 100 patients (a systematic 5% sample), for eligibility
screening. We used this approach to case identification to protect against post-randomisation
selection bias.
Data were collected using structured case review forms. As no patient identifiable data were
sent to the central trial team, we did not require patient consent as confirmed by the Declara-
tion of Helsinki and the NHS Research Ethics Committee. We trained data collectors, mainly
doctors who were undertaking speciality training and nurses, via face-to-face meetings and/or
written briefing materials.
We collected data to assess time from admission to a range of investigations and interven-
tions (e.g. lumbar puncture, aciclovir treatment and neuroimaging). We also collected data to
assess the appropriateness of lumbar punctures and aciclovir dosages (contraindications,
weight, and renal function). We reduced the number of items in the form following pre-inter-
vention data collection to facilitate post-intervention data collection.
Sample size
Using preliminary unpublished data from another Brain Infections UK study of 315 patients
across 26 hospitals in four deaneries, we estimated the standard deviations of the deanery and
hospital random effects to be 0.244 and 1.108, respectively, and the pre-intervention
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proportion of adherence to the primary outcome to be 5%. Assuming a 15% absolute increase
in adherence to the primary outcome measure to 20% in intervention hospitals and identifica-
tion of 20 cases in each of 24 hospitals, we calculated the required sample size to achieve at
least 80% power, testing at the 5% level of significance, as follows.
Using the proposed analysis plan (see “Analysis” below) we simulated data under the stated
assumptions, analysed the data using the glmer() function of the lme4 package in R [47] and
calculated the p-value of the generalised likelihood ratio test of the null hypothesis of no treat-
ment effect. We then repeated the simulation and used the observed proportion of simulated
p-values less than 0.05 as an estimate of the power, stopping the simulations when the negligi-
ble Monte Carlo error became negligible. This gave the required sample size per hospital as 20
patients; to allow for possible under-recruitment in some of the smaller hospitals, we therefore
sought to recruit 25 patients per hospital, but to close recruitment when we achieved a total of
at least 560 patients.
Randomisation
We used deaneries as the unit of randomisation to minimise contamination between hospitals
within the same deanery. We defined two blocks of deaneries, a block of six where research
teams were already actively involved in other ENCEPH UK studies prior to our RCT starting
site recruitment, and a block of six where there were no such ongoing studies (Fig 1). No hospi-
tal was able to take part in this study if they were already involved in any other part of the
ENCEPH UK programme. A statistician (PD) randomised equal numbers of clusters within
each block to the intervention and routine arms, blinded to hospital identity. There was no con-
cealment to randomisation allocation at the cluster level given the nature of the intervention.
Analysis
We assessed primary and secondary outcomes as described above. We estimated the appropri-
ateness of paediatric aciclovir treatment using 5th and 95th percentiles of estimated weight and
length [48] when values were missing. Where values for adult weight were missing, we
assumed weights of 50–70kg for women and 60–80kg for men to allow us to estimate appro-
priateness of aciclovir dosage in adults. A reduced dose was considered appropriate in patients
with recorded renal impairment.
The primary analysis fitted a generalised linear mixed model with binomial errors, logistic
link, fixed effects for treatment (control versus intervention) and block (high or low level of
previous involvement for the deanery in the ENCEPH UK research programme), and random
effects for deanery and hospital [35]. Formally, if pbtdh denotes the probability of a positive out-
come (y = 1) in block b, treatment arm t, deanery d and hospital h, the model is that:
Log
pbtdh
1   bbtdh
� �
¼ ab þ bt þ Ud þ Vh1
where the Ud are independent, Normally distributed with mean zero and variance s2d and the
Vh are independent, Normally distributed with mean zero and variance s2h. The quantity of
interest is the treatment effect, β1−β0, where t = 0 and t = 1 denote control and intervention,
respectively.
We fitted the model using the glmer() function of the lme4 package in R [48]. Model fit was
checked by examining scatterplots of residuals against fitted values.
We also compared outcomes between adults and children by adding this as a blocking fac-
tor within the statistical analysis. The statistician (PD) remained blind to randomisation allo-
cation for the analysis.
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Patient involvement
A representative from the Encephalitis Society was involved in the study design with the par-
ticular remit of ensuring the research retained patient benefit as a primary objective, as well as
providing subsequent opportunities for the study findings to be disseminated to a wider audi-
ence. Our intervention directly targeted healthcare professionals, aiming to help them over-
come barriers to the timely and appropriate investigation and management of suspected
encephalitis. However, as part of the intervention training the healthcare professionals
received, a patient representative from the Encephalitis Society shared their experience of a
non-timely diagnosis. This patient representative was an active member of the Programme
Steering Committee and advised on the study design, outcome selection and conduct. The
intervention was designed to promote best clinical practice, and thus there should have been
no additional intervention burden to patients. Individual patient consent was not required as
patient data were retrospectively collected by members of their own healthcare teams and
anonymised.
Ethical review
This project was approved by Preston North West Research Ethics Committee on 3rd May
2013 (13/NW/0279).
Results
We recruited a total of 24 hospitals from 12 of the 19 UK teaching deaneries. Following rando-
misation by deanery, there were 13 hospitals within six intervention deaneries and 11 hospitals
within six control deaneries. A mix of large tertiary and smaller district general hospitals was
recruited, broadly representing national provision. We identified 489 patients with suspected
encephalitis, 266 in intervention hospitals and 223 in control hospitals. The number of hospi-
tals per deanery ranged from one to four and number of cases from one to 38 (mean 20.4).
The mean patient age was lower in intervention hospitals (45 years, standard deviation [SD] of
30) compared with controls (51 [27.6] years) as was the percentage of males (45.7% and 50%
respectively; Table 1) demonstrating similar characteristics across both study arms. Case ascer-
tainment was similar across both the control and intervention arms. The CONSORT diagram
summarises recruitment, participation, and analysis (Fig 1 and S1 Table).
There was marked variation between hospitals across both arms in adherence to the pri-
mary outcome (range 0% to 40%; interquartile range 4.71% to 21.74%). Across both interven-
tion and control hospitals, overall pre-intervention adherence to the primary outcome was
8.5% (36 out of 422 patients) and post-intervention adherence was 14.1%.
Table 2 summarises crude estimates of the treatment effect for the primary and secondary
outcomes without adjustment for clustering or covariate effects. Achievement of the primary
outcome was 13.5% in intervention hospitals and 14.8% in controls.
Modelling indicated no significant difference between intervention and control hospitals
for the primary outcome of a lumbar puncture performed within 12 hours of hospital admis-
sion and aciclovir given within 6 hours (estimated treatment effect -0.188 with standard error
0.377; p = 0.619; 95% confidence interval [CI] -0:927, 0.552). There was also no significant
intervention effect for any of the seven secondary outcomes (Table 3). For the seventh second-
ary outcome of appropriate dosing of aciclovir administration, although across the whole sam-
ple, children were significantly less likely than adults to be prescribed correct doses of aciclovir
Fig 1. ENCEPH Cluster RCT CONSORT flow diagram. Fig 1 represents recruitment through both control and intervention arms in this study.
https://doi.org/10.1371/journal.pone.0202257.g001
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Table 1. Characteristics of hospital sites.
Intervention Control
Number of hospitals 13 11
Number of patients recruited 266 223
Mean patient recruitment per site 20.5 20.3
Female 133 (50%) 121 (54.3%)
Average patient age (SD, range) 45 (30,
0 to 100)
51 (27.6,
0 to 97)
Number of adult patients 206 (77.4%) 188 (84.3%)
‘Suspected encephalitis’ recorded in the notes 37 (13.9%) 21 (9.4%)
‘Probable encephalitis’ (or equivalent) recorded in the notes 47 (17.7%) 42 (18.8%)
Number of patients identified using discharge codes 86 (32.3%) 72 (32.3%)
Number of patients identified through aciclovir usage 39 (14.7%) 33 (14.8%)
Number of patients identified through CSF examination 132 (49.6%) 109 (48.9%)
Number of patients identified through performance of a CT head scan 9 (3.4%) 9 (4.0%)
Absolute numbers are displayed for all variables with percentages shown in brackets. Percentages were calculated
using the patient variable against the number of patients within the arm.
https://doi.org/10.1371/journal.pone.0202257.t001
Table 2. Crude trial primary and secondary outcomes unadjusted for clustering or covariate effects.
Intervention Control
Number
eligible
Number
meeting
outcome
Percentage Number
eligible
Number
meeting
outcome
Percentage Percentage difference
(95% confidence
interval)
Primary outcome
Lumbar puncture performed within
12 hours and IV aciclovir
administered within 6 hour
Total 266 36 13.53 223 33 14.80 -1.26 (-7.48, 4.95)
Adults 206 25 12.14 190 29 15.26 -3.13 (-9.91, 3.66)
Paediatrics 60 11 18.33 33 4 12.12 6.21 (-8.62, 21.04)
Secondary outcomes:
IV aciclovir administered within 6
hours
Total 266 81 30.45 223 63 28.25 2.20 (-5.89, 10.29)
Adults 206 52 25.24 190 52 27.37 -2.13 (-10.81, 6.56)
Paediatrics 60 29 48.33 33 11 33.33 15.00 (-5.46, 35.46)
Lumbar puncture performed within
12 hours unless there was a clinical
contraindication
Total 266 70 26.32 223 66 29.60 -3.28 (-11.27, 4.71)
Adults 206 48 23.30 190 58 30.53 -7.23 (-15.96, 1.50)
Paediatrics 60 22 36.67 33 8 24.24 12.42 (-6.61, 31.46)
Lumbar puncture at any time Total 266 234 87.97 223 209 93.72 -5.75 (-10.79, -0.71)
Adults 206 180 87.38 190 178 93.68 -6.31 (-12.01, -0.60)
Paediatrics 60 54 90.00 33 31 93.94 -3.94 (-15.07, 7.19)
Lumbar puncture with CSF/serum
glucose ratio calculated
Total 266 86 32.33 223 78 35.00 -2.65 (-11.06, 5.77)
Adults 206 65 31.55 190 65 34.21 -2.66 (-11.92, 6.60)
Paediatrics 60 21 35.00 33 13 39.39 -4.39 (-24.98, 16.19)
Lumbar puncture and a sample taken
for HSV PCR
Total 266 182 68.42 223 175 78.48 -10.05 (-17.82, -2.29)
Adults 206 141 68.45 190 147 77.37 -8.92 (-17.62, -0.22)
Paediatrics 60 41 68.33 33 28 84.85 -16.52 (-33.49, 0.46)
CT or MRI within 24 hours Total 266 153 57.52 223 120 53.81 3.71 (-5.13, 12.54)
Adults 206 129 62.62 190 112 58.95 3.67 (-5.95, 13.30)
Paediatrics 60 24 40.00 33 8 24.24 15.76 (-3.41, 34.93)
Appropriate dose of aciclovir
administered
Total 266 136 51.13 223 131 58.74 -7.62 (-16.44, 1.21)
Adults 206 122 59.22 190 119 62.63 -3.41 (-13.02, 6.20)
Paediatrics 60 14 23.33 33 12 36.36 -13.03 (-32.62, 6.56)
Primary and secondary outcomes for control and intervention arms across all adults and paediatric patients. Number eligible shows denominator.
https://doi.org/10.1371/journal.pone.0202257.t002
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(estimated effect -1.073 with standard error 0.412; p = 0.009; Table 4). There was no significant
interaction between intervention and age group for this nor or any other secondary outcome
(Table 5).
Estimated variances of the random effects for deanery and hospital were 2.73x10-5 and 0.18,
respectively. These were substantially smaller than we had anticipated, possibly because they
had been estimated from an earlier dataset without covariates, whereas we were able to adjust
for the effects of covariates in our actual analysis.
Discussion
A multifaceted implementation strategy based on identified barriers to change had no effect
on the initial hospital management of patients with suspected encephalitis. Overall adherence
to recommended practice remained low despite evidence of a modest overall improvement
across both intervention and control sites compared with the pre-intervention period.
Although most patients had a lumbar puncture at some point, less than a third had a lumbar
puncture within 12 hours of admission. Furthermore, less than a third were prescribed aciclo-
vir within six hours of admission. There are still major challenges facing any drive to improve
initial care for suspected encephalitis. Our evaluation represents a clear advance on previous
intervention studies targeting suspected encephalitis, improving validity by use of a rando-
mised design and generalisability by including multiple sites across the UK [1,3,49]. Our the-
ory-informed implementation strategy was tailored according to identified needs and barriers
and based upon interventions and resources typically available to improve quality of care [30].
There were five main study limitations. First, there was a threat to internal validity of post-
randomisation selection bias, whereby greater awareness of the trial amongst intervention
compared with control hospitals could have influenced identification of cases of suspected
encephalitis and differentially affected case mix and attainment of study outcomes. We stan-
dardised and maximised case identification by combining methods. The mean number of sus-
pected cases identified per site, methods of identification and patient demographic factors
were similar between intervention and control site. Second, retrospective data collection
depended upon the quality of routine clinical recording, which was variable. There was a con-
sistent lack of recording of patient weight upon admission across both trial arms. We therefore
Table 3. Maximum likelihood estimates of intervention effect for secondary outcomes.
Secondary outcome Estimate Standard error p-value
Lumbar puncture performed within 12 hours unless there was a clinical contraindication - 0.11 0.30 0.73
Lumbar puncture at any time - 0.75 0.43 0.08
CT or MRI within 24 hours 0.17 0.38 0.66
Lumbar puncture with CSF/serum glucose ratio calculated 0.12 0.43 0.78
Lumbar puncture and a sample taken for HSV PCR 0.16 0.70 0.82
IV aciclovir administered within 6 hours 0.10 0.36 0.78
https://doi.org/10.1371/journal.pone.0202257.t003
Table 4. Estimates of fixed effects in the model for the secondary outcome, correct administration of aciclovir.
Parameter Estimate Standard error p-value
Intercept 0.68 0.19 0.00
Block -0.37 0.21 0.74
Treatment -0.12 0.23 0.60
Age group -1.07 0.41 0.01
Interaction -0.60 0.54 0.26
https://doi.org/10.1371/journal.pone.0202257.t004
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used estimates and assumptions to assess appropriateness of aciclovir dosage in adults and
children. Third, following initial training and provision of materials, much intervention deliv-
ery was delegated to clinicians in each hospital; this is likely to have resulted in variable fidelity
of intervention delivery. However, within a pragmatic trial, the implementation strategy
reflected what could reasonably be achieved within limited national and local resources [46].
Fourth, our composite outcome measure may have set the bar too high, so that both perform-
ing lumbar punctures and prescribing aciclovir within limited time periods might have been
too difficult to achieve within busy emergency care settings. However, we found no differences
in any of the other less time-contingent secondary outcomes, suggesting that our primary out-
come was not too strict. Fifth, our negative findings, as is generally the case, may yet be
explained by a lack of statistical power. Basing our sample size upon an absolute increase of
15%, from 5% to 20%, in adherence to the primary outcome looks over-optimistic in hind-
sight. However, our estimates of effect size were within the ranges of those typically reported
for other implementation trials [31], we had selected a primary endpoint with low baseline
performance and hence considerable scope for improvement, and we had hoped to leverage
additional effects by tailoring our intervention to identified barriers. Again, the absence of any
signals suggesting an intervention benefit across any of the outcomes use indicates that a lack
of statistical power is unlikely to explain our negative findings.
Our multifaceted implementation strategy was designed to address multiple barriers to the
recommended management of suspected encephalitis. We provide further evidence that multi-
faceted strategies cannot be assumed to be more effective than single interventions although
there is a lack of head-to-head comparisons and a risk of confounding by indication (i.e. inves-
tigators may select multiple interventions to address more challenging implementation prob-
lems).[50, 51] We also show that one approach to theory-guided, intervention tailoring did
not work for this targeted problem and context.
One possible explanation for the lack of any intervention effect is that any modest interven-
tion effects may have been overshadowed by wider improving trends in the management of
patients with suspected encephalitis. Adherence to several outcomes, including time to lumbar
puncture and time to aciclovir, in both trial arms was comparable or better than earlier studies
[1–3,5,9,11–13,18–21,49]. We also observed an improvement in the primary outcome from
8.5% to 14.1% across all intervention and control hospitals over the study period; although this
could partly be explained by changes we made following pre-intervention data collection to
facilitate case identification. Furthermore, our implementation strategy aimed to deliver
improvements over and above existing trends.
The most plausible explanation for the lack of intervention effect is that, coupled with vari-
able fidelity of delivery, our intervention simply failed to target the key determinants of adher-
ence to recommended practice and overcome multiple barriers and competing priorities
within pressurised acute care settings. Other major and better resourced improvement initia-
tives targeting hospital care have also failed to translate into improved frontline patient care
Table 5. Maximum likelihood estimates of interaction effect between treatment and age group for secondary outcomes.
Secondary outcome Estimate Standard error p-value
Lumbar puncture performed within 12 hours unless there was a clinical contraindication 0.79 0.62 0.21
Lumbar puncture at any time 0.10 1.01 0.92
CT or MRI within 24 hours 0.42 0.62 0.49
Lumbar puncture with CSF/serum glucose ratio calculated -0.42 0.69 0.54
Lumbar puncture and a sample taken for HSV PCR -0.62 1.18 0.60
IV aciclovir administered within 6 hours 0.12 0.36 0.74
https://doi.org/10.1371/journal.pone.0202257.t005
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[52,53]. Our trial findings are a pertinent reminder of the need for rigorous, controlled evalua-
tions of quality improvement strategies [54].
The majority of implementation studies have generally targeted the care of more prevalent,
long-term conditions [30]. Although the presentation of suspected encephalitis as opposed to
confirmed encephalitis is not uncommon, it is rarer compared with other emergencies, such as
suspected stroke. It is likely that a more sustained or different type of approach may be neces-
sary to embed recommended initial management into clinician cognitions and routines [51].
Nevertheless, it is still notable that there was some divergence between paediatric and adult
outcomes, with non-significant trends towards timely lumbar puncture and aciclovir adminis-
tration in intervention hospitals according to crude effect estimates. Our trial was insufficiently
powered to detect any such sub-group effects but it may be the case that our intervention
might have had greater leverage within the context of acute paediatric care, where there is a
greater emphasis on the rapid detection and treatment of suspected CNS infections [5].
There is a growing evidence base on the effects of implementation strategies. For example,
the relatively modest effects of audit and feedback can be enhanced by ensuring feedback is
delivered in both written and verbal formats, is provided more than once, and includes both
explicit targets and an action plan [55]. There are therefore opportunities to strengthen the
content and delivery of implementation strategies [56], although any subsequent benefits need
to be weighed up against the increased costs of more intensive strategies [57].
Conclusion
Clinicians struggle to achieve timely diagnosis and management of encephalitis in hospital
emergency settings, leading to worse patient outcomes. A randomised trial of an implementa-
tion strategy tailored to identified barriers and enablers and comprising a range of interven-
tions which could reasonably be delivered within available resources for quality improvement
had no effect on patient care, though there were signals of improved management for children.
The failure to show an effect in the intervention hospitals may partly be because of generally
improved management over time in all hospitals. Different approaches, such as targeting
by type of clinical presentation rather than by specific condition, need to be developed and
evaluated to improve the care of suspected encephalitis and similar challenging clinical
presentations.
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